Magdalena Lixandru
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Magdalena Lixandru has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Cosmin Ionuț Lixandru
Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania
2 shared publications - Florin Grosu
Faculty of Medicine, “Lucian Blaga” University of Sibiu, 550169 Sibiu, Romania
2 shared publications - Ionela Maniu
Faculty of Sciences, Department of Mathematics and Informatics, Research Center in Informatics and Information Technology, Lucian Blaga University of Sibiu, 550024 Sibiu, Romania
2 shared publications - Carmen Daniela Domnariu
Department of Dental Medicine and Nursing, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 550024 Sibiu, Romania
1 shared publication Cosmin Ionuț Lixandru
Faculty of Medicine, Lucian Blaga University, Sibiu, Romania
1 shared publicationFlorin Grosu
Faculty of Medicine, Lucian Blaga University, Sibiu, Romania
1 shared publication
Latest Publications
- Open Access
- 21 May 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (5) , 97
Changes in Coagulation Parameters and Metabolic Profile in Hospitalized Patients with Metabolic Dysfunction-Associated Steatohepatitis Receiving Vitamin K: A Retrospective Observational Study
Background/Objectives: Metabolic dysfunction-associated steatohepatitis (MASH) is frequently accompanied by disturbances in coagulation and metabolic homeostasis, partly related to impaired handling of vitamin K-dependent pathways. Although vitamin K is often administered to correct abnormal coagulation tests, its biochemical impact in hospitalized patients with MASH remains insufficiently characterized. This study aimed to evaluate changes in coagulation and metabolic parameters in hospitalized patients with MASH receiving vitamin K supplementation. Methods: We conducted a retrospective study of 84 hospitalized MASH patients who received vitamin K supplementation. Biochemical parameters were recorded at admission and discharge to assess short-term changes during hospitalization. Results: Vitamin K supplementation was associated with modest changes in coagulation parameters, including reductions in PT, INR, and aPTT (e.g., PT decreased from 13.00 s to 11.00 s). Small numerical changes in transaminases, fasting glucose, and total cholesterol were observed during hospitalization, with limited clinical relevance. These patterns were comparable across fibrosis stages, with no significant differences between groups. Discussion: The observed biochemical findings are likely in-hospital factors rather than a direct metabolic effect of vitamin K. Conclusions: Vitamin K supplementation was associated with modest changes in coagulation parameters and small, clinically negligible variations in selected metabolic markers in patients with MASH, irrespective of fibrosis stage. These findings suggest a supportive biochemical effect in selected contexts; further prospective studies are needed to clarify their clinical relevance.
- 21 May 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (5) , 97
Open AccessChanges in Coagulation Parameters and Metabolic Profile in Hospitalized Patients with Metabolic Dysfunction-Associated Steatohepatitis Receiving Vitamin K: A Retrospective Observational Study
Background/Objectives: Metabolic dysfunction-associated steatohepatitis (MASH) is frequently accompanied by disturbances in coagulation and metabolic homeostasis, partly related to impaired handling of vitamin K-dependent pathways. Although vitamin K is often administered to correct abnormal coagulation tests, its biochemical impact in hospitalized patients with MASH remains insufficiently characterized. This study aimed to evaluate changes in coagulation and metabolic parameters in hospitalized patients with MASH receiving vitamin K supplementation. Methods: We conducted a retrospective study of 84 hospitalized MASH patients who received vitamin K supplementation. Biochemical parameters were recorded at admission and discharge to assess short-term changes during hospitalization. Results: Vitamin K supplementation was associated with modest changes in coagulation parameters, including reductions in PT, INR, and aPTT (e.g., PT decreased from 13.00 s to 11.00 s). Small numerical changes in transaminases, fasting glucose, and total cholesterol were observed during hospitalization, with limited clinical relevance. These patterns were comparable across fibrosis stages, with no significant differences between groups. Discussion: The observed biochemical findings are likely in-hospital factors rather than a direct metabolic effect of vitamin K. Conclusions: Vitamin K supplementation was associated with modest changes in coagulation parameters and small, clinically negligible variations in selected metabolic markers in patients with MASH, irrespective of fibrosis stage. These findings suggest a supportive biochemical effect in selected contexts; further prospective studies are needed to clarify their clinical relevance.
- Open Access
- 1 April 2026
- Vol. 19 (4) , 316-321
Effects of vitamin K administration on liver function, inflammation, and coagulation in chronic viral hepatitis: a retrospective study
Vitamin K is essential for coagulation and has increasingly been recognized for its potential role in inflammatory processes. In patients with chronic viral hepatitis, alterations in coagulation parameters and persistent systemic inflammation are frequently observed. This study aimed to evaluate the association between vitamin K administration and changes in liver enzymes, inflammatory markers, and coagulation parameters in patients with chronic viral hepatitis. This retrospective observational study included 94 patients with chronic viral hepatitis hospitalized between January 2020 and December 2024. Laboratory parameters reflecting liver function, inflammatory status, and coagulation profile were assessed at admission and discharge following vitamin K administration. Changes in biological parameters were analyzed using non-parametric tests for paired data. Reductions in liver enzymes, inflammatory markers, and coagulation parameters were observed between admission and discharge. Aspartate aminotransferase and alanine aminotransferase levels decreased, accompanied by lower values of C-reactive protein and erythrocyte sedimentation rate. Coagulation parameters, including prothrombin time and international normalized ratio, also decreased. No significant differences were identified between patients with and without hepatitis B infection. Vitamin K administration in patients with chronic viral hepatitis was associated with changes in liver enzymes, inflammatory markers, and coagulation parameters. These findings suggest a potential role for vitamin K in the interplay between inflammation and hemostasis in chronic liver disease, while its clinical utility should be considered on an individual basis.
- 1 April 2026
- Vol. 19 (4) , 316-321
Open AccessEffects of vitamin K administration on liver function, inflammation, and coagulation in chronic viral hepatitis: a retrospective study
Vitamin K is essential for coagulation and has increasingly been recognized for its potential role in inflammatory processes. In patients with chronic viral hepatitis, alterations in coagulation parameters and persistent systemic inflammation are frequently observed. This study aimed to evaluate the association between vitamin K administration and changes in liver enzymes, inflammatory markers, and coagulation parameters in patients with chronic viral hepatitis. This retrospective observational study included 94 patients with chronic viral hepatitis hospitalized between January 2020 and December 2024. Laboratory parameters reflecting liver function, inflammatory status, and coagulation profile were assessed at admission and discharge following vitamin K administration. Changes in biological parameters were analyzed using non-parametric tests for paired data. Reductions in liver enzymes, inflammatory markers, and coagulation parameters were observed between admission and discharge. Aspartate aminotransferase and alanine aminotransferase levels decreased, accompanied by lower values of C-reactive protein and erythrocyte sedimentation rate. Coagulation parameters, including prothrombin time and international normalized ratio, also decreased. No significant differences were identified between patients with and without hepatitis B infection. Vitamin K administration in patients with chronic viral hepatitis was associated with changes in liver enzymes, inflammatory markers, and coagulation parameters. These findings suggest a potential role for vitamin K in the interplay between inflammation and hemostasis in chronic liver disease, while its clinical utility should be considered on an individual basis.
- Open Access
- 18 October 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (10) , 188
Effects of Vitamin K Administration in Correcting Coagulopathy in Patients with Liver Cirrhosis: Retrospective Clinical Study
Background/Objectives: Coagulopathy is a common complication of liver cirrhosis, partly due to impaired synthesis of vitamin K-dependent coagulation factors. Despite its frequent use, the efficacy of vitamin K in this setting remains uncertain. This study aimed to evaluate the effect of vitamin K administration on coagulation parameters in patients with cirrhosis. Methods: We performed a retrospective study of 122 cirrhotic patients hospitalized between 2020 and 2024, who received vitamin K for coagulopathy correction. Coagulation and liver function parameters were monitored over time. Results: An early and progressive improvement in INR values was observed, in a subset of patients, following vitamin K administration. INR values across time points were strongly correlated, while only weak associations were observed with bilirubin levels. These findings support a selective therapeutic effect, rather than universal efficacy. Discussion: Despite current guidelines discouraging routine vitamin K use in cirrhosis, our findings suggest that selected patients—particularly those with reversible deficiency—may benefit from supplementation. The observed decrease in INR values supports a targeted, context-based approach rather than empirical management. Conclusions: However, due to the retrospective design and absence of a control group, the observed improvements cannot be conclusively attributed to vitamin K administration. Vitamin K may improve coagulation in cirrhotic patients with reversible deficiency, but its efficacy is not universal. Its use should be individualized and guided by clinical and biochemical context, as part of a broader treatment strategy.
- 18 October 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (10) , 188
Open AccessEffects of Vitamin K Administration in Correcting Coagulopathy in Patients with Liver Cirrhosis: Retrospective Clinical Study
Background/Objectives: Coagulopathy is a common complication of liver cirrhosis, partly due to impaired synthesis of vitamin K-dependent coagulation factors. Despite its frequent use, the efficacy of vitamin K in this setting remains uncertain. This study aimed to evaluate the effect of vitamin K administration on coagulation parameters in patients with cirrhosis. Methods: We performed a retrospective study of 122 cirrhotic patients hospitalized between 2020 and 2024, who received vitamin K for coagulopathy correction. Coagulation and liver function parameters were monitored over time. Results: An early and progressive improvement in INR values was observed, in a subset of patients, following vitamin K administration. INR values across time points were strongly correlated, while only weak associations were observed with bilirubin levels. These findings support a selective therapeutic effect, rather than universal efficacy. Discussion: Despite current guidelines discouraging routine vitamin K use in cirrhosis, our findings suggest that selected patients—particularly those with reversible deficiency—may benefit from supplementation. The observed decrease in INR values supports a targeted, context-based approach rather than empirical management. Conclusions: However, due to the retrospective design and absence of a control group, the observed improvements cannot be conclusively attributed to vitamin K administration. Vitamin K may improve coagulation in cirrhotic patients with reversible deficiency, but its efficacy is not universal. Its use should be individualized and guided by clinical and biochemical context, as part of a broader treatment strategy.
- Open Access
- 21 February 2024
- Published by MDPI AG in Dentistry Journal
- Vol. 12 (3) , 45
Patient Satisfaction with the Quality of Oral Rehabilitation Dental Services: A Comparison between the Public and Private Health System
Measuring satisfaction can help us understand patients’ expectations and adopt individualized treatment according to their expectations. In the current study, we applied the DPQ (Dental Practice Questionnaire) to analyze the degree of patient satisfaction regarding medical services in the public and private sector in a Romanian city from the central region. A group of 200 patients, 100 patients from the public sector and 100 patients from the private sector, participated in the survey. The results showed significant differences in response when patients were stratified by age, gender, visit frequency and length of time attending the same practice. Significant differences between public and private practices were encountered. Moreover, the degree of patient satisfaction was found to be related to appointment promptness/length of time and the confidentiality/ability to listen/knowledge/respect shown by the dentist, while patients’ recommendations to others were influenced by dentists’ explanations and warmth, followed by the appointment system and confidentiality. Patient satisfaction with oral rehabilitation dental services plays an essential role in maintaining patients’ addressability, but there is a multitude of factors that can influence patients’ opinions. Further analysis of the evolution of the influencing factors (causing satisfaction or dissatisfaction), in time, could provide deeper insights into the links between patient satisfaction and these factors.
- 21 February 2024
- Published by MDPI AG in Dentistry Journal
- Vol. 12 (3) , 45
Open AccessPatient Satisfaction with the Quality of Oral Rehabilitation Dental Services: A Comparison between the Public and Private Health System
Measuring satisfaction can help us understand patients’ expectations and adopt individualized treatment according to their expectations. In the current study, we applied the DPQ (Dental Practice Questionnaire) to analyze the degree of patient satisfaction regarding medical services in the public and private sector in a Romanian city from the central region. A group of 200 patients, 100 patients from the public sector and 100 patients from the private sector, participated in the survey. The results showed significant differences in response when patients were stratified by age, gender, visit frequency and length of time attending the same practice. Significant differences between public and private practices were encountered. Moreover, the degree of patient satisfaction was found to be related to appointment promptness/length of time and the confidentiality/ability to listen/knowledge/respect shown by the dentist, while patients’ recommendations to others were influenced by dentists’ explanations and warmth, followed by the appointment system and confidentiality. Patient satisfaction with oral rehabilitation dental services plays an essential role in maintaining patients’ addressability, but there is a multitude of factors that can influence patients’ opinions. Further analysis of the evolution of the influencing factors (causing satisfaction or dissatisfaction), in time, could provide deeper insights into the links between patient satisfaction and these factors.